Key Insights
The United States computed tomography (CT) market is a significant segment within the broader medical imaging industry, exhibiting robust growth driven by several key factors. The market, valued at approximately $2.38 billion in 2025 (assuming this figure represents the US market within the broader global data), is projected to experience a Compound Annual Growth Rate (CAGR) of 5.86% from 2025 to 2033. This growth is fueled by increasing prevalence of chronic diseases like cancer and cardiovascular conditions necessitating advanced diagnostic tools. Technological advancements, such as multi-slice CT scanners offering faster scan times and improved image quality, further contribute to market expansion. The rise in the geriatric population, prone to multiple health issues requiring frequent CT scans, also presents a significant driver. Furthermore, increasing healthcare spending and insurance coverage for advanced imaging techniques within the United States fuel demand. The market is segmented by type (low, medium, and high slice CT scanners), application (oncology, neurology, cardiovascular, musculoskeletal, and others), and end-user (hospitals, diagnostic centers, and others). Hospitals constitute the largest end-user segment, benefiting from high patient volumes and the availability of comprehensive diagnostic capabilities. The presence of established players like GE Healthcare, Siemens Healthineers, and Canon Medical Systems, along with emerging players, fosters competition and innovation within the market. However, high costs associated with CT scanners and procedures, alongside concerns regarding radiation exposure, pose certain restraints.
The ongoing shift towards minimally invasive procedures necessitates accurate and precise imaging, bolstering the demand for advanced CT technologies. The development and adoption of AI-powered image analysis tools promise faster and more accurate diagnoses, leading to improved patient outcomes and efficiency in clinical workflows. This trend is expected to drive further market growth over the forecast period. The US market's strong healthcare infrastructure and relatively high per capita healthcare expenditure, compared to many global regions, create a favorable environment for the continuous expansion of the CT market. Competition among major players will likely continue to drive innovation and price optimization. Regional disparities in access to advanced imaging technologies might exist, but the overall market trajectory suggests sustained growth, driven by technological progress and expanding healthcare needs within the United States.

United States Computed Tomography Market: A Comprehensive Report (2019-2033)
This detailed report provides a comprehensive analysis of the United States Computed Tomography (CT) market, offering invaluable insights for industry stakeholders, investors, and strategic decision-makers. The report covers the period from 2019 to 2033, with 2025 as the base year and a forecast period extending to 2033. We delve into market segmentation, competitive dynamics, technological advancements, and growth drivers to present a complete picture of this vital sector.
United States Computed Tomography Market Market Concentration & Innovation
The US Computed Tomography market exhibits a moderately concentrated landscape, dominated by a handful of multinational corporations. Key players like GE Healthcare, Siemens Healthineers AG, and Koninklijke Philips NV hold significant market share, leveraging their extensive product portfolios and global reach. However, smaller players and innovative startups are emerging, driving competition and technological advancements. Market share data for 2024 suggests GE Healthcare holds approximately xx% market share, followed by Siemens Healthineers AG with xx%, and Koninklijke Philips NV with xx%. The remaining share is distributed among other players, including Canon Medical Systems Corporation, Neusoft Medical Systems Co Ltd, and others.
Mergers and acquisitions (M&A) activity has played a crucial role in shaping the market landscape. While precise M&A deal values for the period are not publicly available for all transactions, recent years have seen several significant acquisitions focused on expanding product lines and geographic reach, resulting in an increased concentration of market power among the leading players. This consolidation is driven by the high capital investment required for research and development and the need for extensive distribution networks.
Several factors drive innovation in the CT market. These include:
- Regulatory Frameworks: Stringent regulatory requirements drive manufacturers to enhance safety, efficacy, and diagnostic capabilities.
- Technological Advancements: The constant pursuit of higher resolution imaging, faster scan times, and reduced radiation exposure fuels continuous product innovation.
- Product Substitutes: The emergence of alternative imaging modalities, such as MRI and Ultrasound, compels CT manufacturers to improve their offerings and justify the advantages of CT technology.
- End-User Trends: Growing demand for faster, more efficient, and patient-friendly diagnostic imaging drives the development of advanced CT systems.
United States Computed Tomography Market Industry Trends & Insights
The US Computed Tomography market experienced robust growth during the historical period (2019-2024), with a Compound Annual Growth Rate (CAGR) of xx%. This growth is attributed to several key factors:
- Increasing Prevalence of Chronic Diseases: The rising incidence of cardiovascular diseases, cancer, and neurological disorders fuels the demand for accurate and efficient diagnostic imaging.
- Technological Advancements: The introduction of multi-slice CT scanners, advanced image reconstruction techniques, and AI-powered image analysis has significantly improved diagnostic accuracy and efficiency.
- Aging Population: An aging population increases the demand for advanced diagnostic imaging solutions for various age-related conditions.
- Rising Healthcare Expenditure: Increased healthcare spending in the US enables greater adoption of advanced medical technologies, including CT scanners.
- Technological Disruptions: The integration of Artificial Intelligence (AI) and machine learning (ML) in CT imaging is transforming the field, increasing automation, and enhancing diagnostic accuracy. This has improved workflow efficiency and allowed for faster image processing. Market penetration of AI-enabled CT scanners is currently at xx% and is projected to reach xx% by 2033. This is due to its ability to improve speed, precision, and detection of anomalies.
Competitive dynamics remain intense, with leading players focusing on product differentiation, technological innovation, and strategic partnerships to maintain their market positions. The market is also witnessing increased competition from emerging players offering cost-effective and specialized CT solutions.

Dominant Markets & Segments in United States Computed Tomography Market
The US Hospitals segment dominates the end-user landscape, accounting for the largest share of the CT market. This is due to hospitals' higher capacity to handle advanced technologies and increased patient volume. Diagnostic centers also constitute a significant market segment.
Among application segments, Oncology and Cardiovascular applications are the most prominent, driven by the high prevalence of cancer and cardiovascular diseases, respectively. High-slice CT scanners dominate the market due to their superior image quality and diagnostic capabilities, although medium-slice scanners retain significant market share due to their cost-effectiveness.
Key Drivers of Segment Dominance:
- Hospitals: High patient volume, advanced infrastructure, and access to specialized medical staff.
- Oncology & Cardiovascular Applications: High prevalence of these diseases and the critical need for accurate and timely diagnosis.
- High-Slice CT Scanners: Superior image quality, detailed anatomical resolution, and faster scan times.
United States Computed Tomography Market Product Developments
Recent product innovations in the US CT market are focused on enhancing image quality, reducing radiation exposure, and improving workflow efficiency. Multi-slice CT scanners with advanced reconstruction techniques and AI-powered image analysis are gaining popularity. Mobile CT scanners are also emerging as a significant trend, enabling point-of-care imaging in various settings. These advancements aim to improve diagnostic accuracy, reduce costs, and improve patient outcomes.
Report Scope & Segmentation Analysis
This report segments the US Computed Tomography market based on:
Type:
- Low Slice: This segment is expected to show steady growth, driven by its cost-effectiveness.
- Medium Slice: This segment enjoys robust demand due to its balance of cost and performance.
- High Slice: This segment showcases significant growth potential, owing to its superior image quality and advanced features.
Application:
- Oncology: High growth driven by increasing cancer rates and the need for precise diagnosis and treatment planning.
- Neurology: Steady growth driven by the need for detailed brain imaging.
- Cardiovascular: High growth due to the increasing prevalence of heart diseases.
- Musculoskeletal: Moderate growth, driven by the rising number of musculoskeletal injuries and disorders.
- Other Applications: Includes various niche applications with moderate growth potential.
End User:
- Hospitals: The largest segment, exhibiting high growth due to increased adoption of advanced imaging technologies.
- Diagnostic Centers: A significant segment with steady growth driven by increasing demand for outpatient diagnostic services.
- Other End Users: Includes smaller clinics and specialized facilities with moderate growth potential.
Key Drivers of United States Computed Tomography Market Growth
Several factors drive growth in the US CT market:
- Technological advancements leading to improved image quality, reduced scan times, and lower radiation exposure.
- Rising prevalence of chronic diseases necessitating accurate and timely diagnosis.
- Increased healthcare expenditure allowing for greater adoption of advanced medical technologies.
- Favorable regulatory environment supporting the development and adoption of innovative CT systems.
Challenges in the United States Computed Tomography Market Sector
The US CT market faces several challenges:
- High cost of CT scanners limiting accessibility, particularly in underserved areas.
- Concerns over radiation exposure necessitate ongoing research into radiation reduction techniques.
- Intense competition among established and emerging players puts pressure on pricing and profitability.
- Regulatory hurdles and reimbursement policies can affect market adoption.
Emerging Opportunities in United States Computed Tomography Market
The US CT market presents several promising opportunities:
- Growing demand for point-of-care CT imaging for faster and more convenient diagnostics.
- Increasing adoption of AI and machine learning for improved image analysis and workflow efficiency.
- Expanding applications in various medical specialties beyond traditional applications.
- Focus on developing cost-effective and portable CT scanners to improve accessibility.
Leading Players in the United States Computed Tomography Market Market
- GE Healthcare
- Koning corporation
- Siemens Healthineers AG
- Canon Medical Systems Corporation (Toshiba Corporation)
- Neusoft Medical Systems Co Ltd
- Carestream Health
- Koninklijke Philips NV
- Stryker Corporation
- Planmeca Group (Planmed OY)
- Samsung Electronics Co Ltd
- Fujifilm Holdings Corporation
Key Developments in United States Computed Tomography Market Industry
- June 2022: Xoran Technologies received a patent for a modular computed tomography (CT) system assembly, signifying advancements in point-of-care imaging.
- March 2022: NeuroLogica Corp's OmniTom Elite received 510(k) approval, expanding the availability of mobile CT imaging.
Strategic Outlook for United States Computed Tomography Market Market
The US Computed Tomography market is poised for continued growth, driven by technological innovation, increasing healthcare spending, and the rising prevalence of chronic diseases. Opportunities exist in developing advanced imaging techniques, expanding point-of-care applications, and integrating AI for improved diagnostic accuracy and workflow efficiency. The market's future potential is significant, with continued innovation shaping the landscape and expanding access to this crucial diagnostic modality.
United States Computed Tomography Market Segmentation
-
1. Type
- 1.1. Low Slice
- 1.2. Medium Slice
- 1.3. High Slice
-
2. Application
- 2.1. Oncology
- 2.2. Neurology
- 2.3. Cardiovascular
- 2.4. Musculoskeletal
- 2.5. Other Applications
-
3. End User
- 3.1. Hospitals
- 3.2. Diagnostic Centers
- 3.3. Other End Users
United States Computed Tomography Market Segmentation By Geography
- 1. United States

United States Computed Tomography Market REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 5.86% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increasing Prevalence of Chronic Diseases; Rising Geriatric Population; Increasing Technological Advancements
- 3.3. Market Restrains
- 3.3.1. Lack Of Proper Reimbursement And Stringent Regulatory Approval Procedures; High Cost of Equipment
- 3.4. Market Trends
- 3.4.1. Oncology Segment is Expected to Hold a Significant Market Share Over the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. United States Computed Tomography Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Type
- 5.1.1. Low Slice
- 5.1.2. Medium Slice
- 5.1.3. High Slice
- 5.2. Market Analysis, Insights and Forecast - by Application
- 5.2.1. Oncology
- 5.2.2. Neurology
- 5.2.3. Cardiovascular
- 5.2.4. Musculoskeletal
- 5.2.5. Other Applications
- 5.3. Market Analysis, Insights and Forecast - by End User
- 5.3.1. Hospitals
- 5.3.2. Diagnostic Centers
- 5.3.3. Other End Users
- 5.4. Market Analysis, Insights and Forecast - by Region
- 5.4.1. United States
- 5.1. Market Analysis, Insights and Forecast - by Type
- 6. United States United States Computed Tomography Market Analysis, Insights and Forecast, 2019-2031
- 7. Canada United States Computed Tomography Market Analysis, Insights and Forecast, 2019-2031
- 8. Mexico United States Computed Tomography Market Analysis, Insights and Forecast, 2019-2031
- 9. Competitive Analysis
- 9.1. Market Share Analysis 2024
- 9.2. Company Profiles
- 9.2.1 GE Healthcare
- 9.2.1.1. Overview
- 9.2.1.2. Products
- 9.2.1.3. SWOT Analysis
- 9.2.1.4. Recent Developments
- 9.2.1.5. Financials (Based on Availability)
- 9.2.2 Koning corporation
- 9.2.2.1. Overview
- 9.2.2.2. Products
- 9.2.2.3. SWOT Analysis
- 9.2.2.4. Recent Developments
- 9.2.2.5. Financials (Based on Availability)
- 9.2.3 Siemens Healthineers AG
- 9.2.3.1. Overview
- 9.2.3.2. Products
- 9.2.3.3. SWOT Analysis
- 9.2.3.4. Recent Developments
- 9.2.3.5. Financials (Based on Availability)
- 9.2.4 Canon Medical Systems Corporation (Toshiba Corporation)
- 9.2.4.1. Overview
- 9.2.4.2. Products
- 9.2.4.3. SWOT Analysis
- 9.2.4.4. Recent Developments
- 9.2.4.5. Financials (Based on Availability)
- 9.2.5 Neusoft Medical Systems Co Ltd
- 9.2.5.1. Overview
- 9.2.5.2. Products
- 9.2.5.3. SWOT Analysis
- 9.2.5.4. Recent Developments
- 9.2.5.5. Financials (Based on Availability)
- 9.2.6 Carestream Health
- 9.2.6.1. Overview
- 9.2.6.2. Products
- 9.2.6.3. SWOT Analysis
- 9.2.6.4. Recent Developments
- 9.2.6.5. Financials (Based on Availability)
- 9.2.7 Koninklijke Philips NV
- 9.2.7.1. Overview
- 9.2.7.2. Products
- 9.2.7.3. SWOT Analysis
- 9.2.7.4. Recent Developments
- 9.2.7.5. Financials (Based on Availability)
- 9.2.8 Stryker Corporation
- 9.2.8.1. Overview
- 9.2.8.2. Products
- 9.2.8.3. SWOT Analysis
- 9.2.8.4. Recent Developments
- 9.2.8.5. Financials (Based on Availability)
- 9.2.9 Planmeca Group (Planmed OY)
- 9.2.9.1. Overview
- 9.2.9.2. Products
- 9.2.9.3. SWOT Analysis
- 9.2.9.4. Recent Developments
- 9.2.9.5. Financials (Based on Availability)
- 9.2.10 Samsung Electronics Co Ltd
- 9.2.10.1. Overview
- 9.2.10.2. Products
- 9.2.10.3. SWOT Analysis
- 9.2.10.4. Recent Developments
- 9.2.10.5. Financials (Based on Availability)
- 9.2.11 Fujifilm Holdings Corporation
- 9.2.11.1. Overview
- 9.2.11.2. Products
- 9.2.11.3. SWOT Analysis
- 9.2.11.4. Recent Developments
- 9.2.11.5. Financials (Based on Availability)
- 9.2.1 GE Healthcare
List of Figures
- Figure 1: United States Computed Tomography Market Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: United States Computed Tomography Market Share (%) by Company 2024
List of Tables
- Table 1: United States Computed Tomography Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: United States Computed Tomography Market Revenue Million Forecast, by Type 2019 & 2032
- Table 3: United States Computed Tomography Market Revenue Million Forecast, by Application 2019 & 2032
- Table 4: United States Computed Tomography Market Revenue Million Forecast, by End User 2019 & 2032
- Table 5: United States Computed Tomography Market Revenue Million Forecast, by Region 2019 & 2032
- Table 6: United States Computed Tomography Market Revenue Million Forecast, by Country 2019 & 2032
- Table 7: United States United States Computed Tomography Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 8: Canada United States Computed Tomography Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 9: Mexico United States Computed Tomography Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 10: United States Computed Tomography Market Revenue Million Forecast, by Type 2019 & 2032
- Table 11: United States Computed Tomography Market Revenue Million Forecast, by Application 2019 & 2032
- Table 12: United States Computed Tomography Market Revenue Million Forecast, by End User 2019 & 2032
- Table 13: United States Computed Tomography Market Revenue Million Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the United States Computed Tomography Market?
The projected CAGR is approximately 5.86%.
2. Which companies are prominent players in the United States Computed Tomography Market?
Key companies in the market include GE Healthcare, Koning corporation, Siemens Healthineers AG, Canon Medical Systems Corporation (Toshiba Corporation), Neusoft Medical Systems Co Ltd, Carestream Health, Koninklijke Philips NV, Stryker Corporation, Planmeca Group (Planmed OY), Samsung Electronics Co Ltd, Fujifilm Holdings Corporation.
3. What are the main segments of the United States Computed Tomography Market?
The market segments include Type, Application, End User.
4. Can you provide details about the market size?
The market size is estimated to be USD 2.38 Million as of 2022.
5. What are some drivers contributing to market growth?
Increasing Prevalence of Chronic Diseases; Rising Geriatric Population; Increasing Technological Advancements.
6. What are the notable trends driving market growth?
Oncology Segment is Expected to Hold a Significant Market Share Over the Forecast Period.
7. Are there any restraints impacting market growth?
Lack Of Proper Reimbursement And Stringent Regulatory Approval Procedures; High Cost of Equipment.
8. Can you provide examples of recent developments in the market?
In June 2022, Xoran Technologies, a United States-based company received a patent for a modular computed tomography (CT) system assembly. Together with our twenty and counting active patents, this ground-breaking cone beam CT arrangement opens up new possibilities. The innovation is just the start of a new line of point-of-care (POC) imaging equipment from Xoran.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "United States Computed Tomography Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the United States Computed Tomography Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the United States Computed Tomography Market?
To stay informed about further developments, trends, and reports in the United States Computed Tomography Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence